Article
Liquid biopsy utility for the surveillance of cutaneous malignant melanoma patients.
Molecular oncology - 1 Mar 2016
Huang Sharon K, Hoon Dave S B
Abstract excerpt
Cutaneous melanoma is one of the highest incident-rate cancers with increasing prevalence in Western societies. Despite the advent of new approved therapeutics, the 5-year overall survival rate of stage IV melanoma patients remains below 15%. Current treatments for late stage disease have shown higher efficacy when treated at a lower disease burden. Thus, blood-based biomarkers capable of detecting melanoma prior...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.